Leodolter A, Ebert MP, Peitz U, Wolle K, Kahl S, Vieth M, Malfertheiner P. Prevalence of H pylori associated ‘high risk gastritis’ for development of gastric cancer in patients with normal endoscopic findings. World J Gastroenterol 2006; 12(34): 5509-5512 [PMID: 17006989 DOI: 10.3748/wjg.v12.i34.5509]
Corresponding Author of This Article
Andreas Leodolter, MD, Department of Gastroenterology and Hepatology, Otto-von-Guericke University, Leipziger Street 44, Magdeburg D-39120, Germany. andreas@Leodolter.de
Article-Type of This Article
Rapid Communication
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Sep 14, 2006; 12(34): 5509-5512 Published online Sep 14, 2006. doi: 10.3748/wjg.v12.i34.5509
Table 1 Age and sex distribution of H pylori positive patients without gross pathology of gastric mucosa during upper GI-endoscopy
Endoscopic normal gastric mucosawith H pylori infection
Number (n)
845
Mean age (yr)
54.8 (18-87)
Sex
Male
450/845 (53.2%)
Female
395/845 (46.8%)
Age (yr)
< 35
114/845 (13.5%)
35-44
120/845 (14.2%)
45-54
151/845 (17.9%)
55-64
199/845 (23.6%)
65-74
166/845 (19.6%)
> 75
95/845 (11.2%)
Table 2 Frequency of intestinal metaplasia (IM) in the gastric antrum and the corpus in patients without macroscopic pathology during upper GI-endoscopy
Age (yr)
Overall IM
IM only inthe antrum
IM only in thecorpus
IM in antrumand corpus
< 35
9/114 (7.9%)
1/114 (0.9%)
7/114 (6.1%)
1/114 (0.9%)
35-44
14/120 (11.7%)
2/120 (1.7%)
12/120 (10.0%)
0/120 (0.0%)
45-54
28/151 (18.5%)
7/151 (4.6%)
18/151 (11.9%)
3/151 (2.0%)
55-64
50/199 (25.1%)
7/199 (3.5%)
35/199 (17.6%)
8/199 (4.0%)
64-75
65/166 (39.2%)
6/166 (3.6%)
51/166 (30.7%)
8/166 (4.8%)
> 75
38/95 (40.0%)
6/95 (6.3%)
24/95 (25.2%)
8/95 (8.4%)
Differences between age groups
P < 0.001 (χ2-test)
P < 0.001 (χ2-test)
P < 0.001 (χ2-test)
P < 0.001 (χ2-test)
Table 3 Frequency of severe atrophy, antrum- and corpus-gastritis score in H pylori positive patients in different age-groups in patients without macroscopic pathology during upper GI-endoscopy
Age (yr)
Severe atrophy
Antrum gastritisscore
Corpus gastritisscore
< 35
0/114 (0.0%)
3.36 ± 0.90
2.49 ± 1.17
35-44
2/120 (1.7%)
3.17 ± 0.86
2.73 ± 1.02
45-54
3/151 (2.0%)
3.32 ± 1.04
2.85 ± 1.04
55-64
4/199 (2.0%)
3.38 ± 0.94
2.93 ± 1.17
64-75
9/166 (5.4%)
3.20 ± 0.92
2.98 ± 1.08
> 75
9/95 (11.2%)
3.08 ± 0.96
3.06 ± 1.15
Differences between age groups
P < 0.001 (χ2-test)
NS (ANOVA)
P < 0.001 (ANOVA)
Table 4 Comparison of gastric cancer risk index and phenotype of gastritis in 845 patients with H pylori positive gastritis
Phenotype of gastritis
Gastric cancer risk index
0 point
1 point
2 points
3 points
Antrum-predominant gastritis
156
104
21
0
Pangastritis
107
178
113
36
Corpus-predominant gastritis
2
22
62
44
Citation: Leodolter A, Ebert MP, Peitz U, Wolle K, Kahl S, Vieth M, Malfertheiner P. Prevalence of H pylori associated ‘high risk gastritis’ for development of gastric cancer in patients with normal endoscopic findings. World J Gastroenterol 2006; 12(34): 5509-5512